Cargando…

Reevaluation of missed lung cancer with artificial intelligence

Lung cancer is often missed on chest radiographs, despite chest radiography typically being the first imaging modality in the diagnosis pathway. We present a 46 year-old male with chest pain referred for chest X-ray, and initial interpretation reported no abnormality within the patient's lungs....

Descripción completa

Detalles Bibliográficos
Autores principales: Sicular, Serge, Alpaslan, Mehmet, Ortega, Francis A., Keathley, Nora, Venkatesh, Srivas, Jones, Rebecca M., Lindsey, Robert V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472074/
https://www.ncbi.nlm.nih.gov/pubmed/36118268
http://dx.doi.org/10.1016/j.rmcr.2022.101733
_version_ 1784789227711496192
author Sicular, Serge
Alpaslan, Mehmet
Ortega, Francis A.
Keathley, Nora
Venkatesh, Srivas
Jones, Rebecca M.
Lindsey, Robert V.
author_facet Sicular, Serge
Alpaslan, Mehmet
Ortega, Francis A.
Keathley, Nora
Venkatesh, Srivas
Jones, Rebecca M.
Lindsey, Robert V.
author_sort Sicular, Serge
collection PubMed
description Lung cancer is often missed on chest radiographs, despite chest radiography typically being the first imaging modality in the diagnosis pathway. We present a 46 year-old male with chest pain referred for chest X-ray, and initial interpretation reported no abnormality within the patient's lungs. The patient was discharged but returned 4 months later with persistent and worsening symptoms. At this time, chest X-ray was again performed and revealed an enlarging left perihilar mass with post-obstructive atelectasis in the left lower lobe. Follow-up chest computerized tomography scan confirmed lung cancer with post-obstructive atelectasis, and subsequent bronchoscopy-assisted biopsy confirmed squamous cell carcinoma. Retrospective analysis of the initial chest radiograph, which had reported normal findings, was performed with Chest-CAD, a Food and Drug Administration (FDA) cleared computer-assisted detection (CAD) software device that analyzes chest radiograph studies using artificial intelligence. The device highlighted the perihilar region of the left lung as suspicious. Additional information provided by artificial intelligence software holds promise to prevent missed detection of lung cancer on chest radiographs.
format Online
Article
Text
id pubmed-9472074
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94720742022-09-15 Reevaluation of missed lung cancer with artificial intelligence Sicular, Serge Alpaslan, Mehmet Ortega, Francis A. Keathley, Nora Venkatesh, Srivas Jones, Rebecca M. Lindsey, Robert V. Respir Med Case Rep Case Report Lung cancer is often missed on chest radiographs, despite chest radiography typically being the first imaging modality in the diagnosis pathway. We present a 46 year-old male with chest pain referred for chest X-ray, and initial interpretation reported no abnormality within the patient's lungs. The patient was discharged but returned 4 months later with persistent and worsening symptoms. At this time, chest X-ray was again performed and revealed an enlarging left perihilar mass with post-obstructive atelectasis in the left lower lobe. Follow-up chest computerized tomography scan confirmed lung cancer with post-obstructive atelectasis, and subsequent bronchoscopy-assisted biopsy confirmed squamous cell carcinoma. Retrospective analysis of the initial chest radiograph, which had reported normal findings, was performed with Chest-CAD, a Food and Drug Administration (FDA) cleared computer-assisted detection (CAD) software device that analyzes chest radiograph studies using artificial intelligence. The device highlighted the perihilar region of the left lung as suspicious. Additional information provided by artificial intelligence software holds promise to prevent missed detection of lung cancer on chest radiographs. Elsevier 2022-08-27 /pmc/articles/PMC9472074/ /pubmed/36118268 http://dx.doi.org/10.1016/j.rmcr.2022.101733 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Sicular, Serge
Alpaslan, Mehmet
Ortega, Francis A.
Keathley, Nora
Venkatesh, Srivas
Jones, Rebecca M.
Lindsey, Robert V.
Reevaluation of missed lung cancer with artificial intelligence
title Reevaluation of missed lung cancer with artificial intelligence
title_full Reevaluation of missed lung cancer with artificial intelligence
title_fullStr Reevaluation of missed lung cancer with artificial intelligence
title_full_unstemmed Reevaluation of missed lung cancer with artificial intelligence
title_short Reevaluation of missed lung cancer with artificial intelligence
title_sort reevaluation of missed lung cancer with artificial intelligence
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472074/
https://www.ncbi.nlm.nih.gov/pubmed/36118268
http://dx.doi.org/10.1016/j.rmcr.2022.101733
work_keys_str_mv AT sicularserge reevaluationofmissedlungcancerwithartificialintelligence
AT alpaslanmehmet reevaluationofmissedlungcancerwithartificialintelligence
AT ortegafrancisa reevaluationofmissedlungcancerwithartificialintelligence
AT keathleynora reevaluationofmissedlungcancerwithartificialintelligence
AT venkateshsrivas reevaluationofmissedlungcancerwithartificialintelligence
AT jonesrebeccam reevaluationofmissedlungcancerwithartificialintelligence
AT lindseyrobertv reevaluationofmissedlungcancerwithartificialintelligence